Try our beta test site
1 study found for:    9748012 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study to Evaluate Safety, Tolerability and Pharmacokinetics of rhNGF Eye Drops in Healthy Volunteers
Condition: Healthy
Interventions: Drug: rhNGF 0.5 µg/mL Sentinel;   Drug: rhNGF 5 µg/mL Sentinel;   Drug: rhNGF 20 µg/mL Sentinel;   Drug: rhNGF 20 µg/mL Part A;   Drug: rhNGF 60 µg/mL Part A;   Drug: rhNGF 180 µg/mL Part A;   Drug: rhNGF 20 µg/mL Part B;   Drug: rhNGF 20 µg/mL Part B cohort 0M;   Drug: rhNGF 60 µg/mL Part B;   Drug: rhNGF 180 µg/mL Part B;   Drug: Placebo Part A;   Drug: Placebo Part B

Study has passed its completion date and status has not been verified in more than two years.